全文获取类型
收费全文 | 8850篇 |
免费 | 927篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 74篇 |
儿科学 | 266篇 |
妇产科学 | 132篇 |
基础医学 | 1228篇 |
口腔科学 | 349篇 |
临床医学 | 1039篇 |
内科学 | 1715篇 |
皮肤病学 | 148篇 |
神经病学 | 620篇 |
特种医学 | 471篇 |
外科学 | 1265篇 |
综合类 | 237篇 |
一般理论 | 6篇 |
预防医学 | 843篇 |
眼科学 | 203篇 |
药学 | 654篇 |
1篇 | |
中国医学 | 1篇 |
肿瘤学 | 548篇 |
出版年
2021年 | 69篇 |
2020年 | 67篇 |
2019年 | 109篇 |
2018年 | 128篇 |
2017年 | 126篇 |
2016年 | 130篇 |
2015年 | 158篇 |
2014年 | 154篇 |
2013年 | 279篇 |
2012年 | 374篇 |
2011年 | 399篇 |
2010年 | 281篇 |
2009年 | 246篇 |
2008年 | 331篇 |
2007年 | 380篇 |
2006年 | 362篇 |
2005年 | 397篇 |
2004年 | 309篇 |
2003年 | 372篇 |
2002年 | 320篇 |
2001年 | 263篇 |
2000年 | 285篇 |
1999年 | 255篇 |
1998年 | 169篇 |
1997年 | 172篇 |
1996年 | 136篇 |
1995年 | 139篇 |
1994年 | 135篇 |
1993年 | 128篇 |
1992年 | 201篇 |
1991年 | 197篇 |
1990年 | 175篇 |
1989年 | 204篇 |
1988年 | 190篇 |
1987年 | 179篇 |
1986年 | 156篇 |
1985年 | 176篇 |
1984年 | 121篇 |
1983年 | 116篇 |
1982年 | 87篇 |
1981年 | 83篇 |
1980年 | 74篇 |
1979年 | 113篇 |
1978年 | 81篇 |
1977年 | 85篇 |
1976年 | 65篇 |
1973年 | 85篇 |
1972年 | 73篇 |
1971年 | 72篇 |
1970年 | 61篇 |
排序方式: 共有9800条查询结果,搜索用时 15 毫秒
1.
Clare Robertson Jan E. Clarkson Magaly Aceves-Martins Craig R. Ramsay Derek Richards Thibault Colloc 《International dental journal》2022,72(2):203-210
IntroductionThe coronavirus disease 2019 (COVID-19) led to the worldwide closure of dental practices or reduction of dental services. By the end of April 2020, governments and professional organisations were publishing recommendations or guidance for the reopening/restructuring of dental services. The aim of this study was to assess how dental aerosol-generating procedures (AGPs) were defined in international dental guidelines, what mitigation processes were advised, and whether they were linked to COVID-19 epidemiology.MethodsElectronic searches of a broad range of databases, along with grey literature searches, without language restriction were conducted up to 13 July 2020. Recommendations for the use of face masks and fallow times with patients without COVID-19 were assessed against the deaths per 1 million population in the included countries and country income level using Pearson Chi-squared statistics.ResultsSixty-three guidance documents were included. Most (98%) indicated that AGPs can be performed with patients without COVID-19 with caveats, including advice to restrict AGPs where possible, with 21% only recommending AGPs for dental emergencies. Face masks were recommended by most documents (94%), with 91% also specifying the use of goggles or face shields. Fallow periods for patients without COVID-19 were mentioned in 48% of documents, ranging from 2 to 180 minutes. There were no significant differences in recommendations for face masks or fallow time in patients without COVID-19 by country death rate (P = .463 and P = .901) or World Bank status (P = .504 and P = .835). Most documents recommended procedural or environmental mitigations such as preprocedural mouthwash (82%) and general ventilation (52%). Few documents provided underpinning evidence for their recommendations.ConclusionsWhile the amount of high-quality direct evidence related to dentistry and COVID-19 remains limited, it is important to be explicit about the considered judgements for recommendations as well as generate new evidence to face this challenge. 相似文献
2.
Hui Yu Zhengming Chen Karla V. Ballman Mark A. Watson Ramaswamy Govindan Irena Lanc David G. Beer Raphael Bueno Lucian R. Chirieac Michael Herman Chui Guoan Chen Wilbur A. Franklin David R. Gandara Carlo Genova Kristine A. Brovsky Mary-Beth M. Joshi Daniel T. Merrick William G. Richards Fred R. Hirsch 《Journal of thoracic oncology》2019,14(1):25-36
Objectives
Anti–programmed cell death 1 (PD-1)/programmed death ligand 1 (PD-L1) immunotherapy has demonstrated success in the treatment of advanced NSCLC. Recently, PD-1/PD-L1 blockade also has demonstrated interesting results in small trials of neoadjuvant treatment in stage IB to IIIA NSCLC. In addition, several clinical trials using anti–PD-1/PD-L1 immunotherapy as an adjuvant or neoadjuvant treatment in patients with resectable stage NSCLC are ongoing. However, few analyses of anti–PD-1/PD-L1 immunotherapy–related biomarkers in early-stage squamous cell lung carcinoma (SqCLC) have been reported. In this study, we evaluated PD-L1 protein expression, tumor mutation burden, and expression of an immune gene signature in early-stage SqCLC, providing data for identifying the potential role for patients with anti–PD-1/PD-L1 treatment in early-stage SqCLC.Methods
A total of 255 specimens from patients with early-stage SqCLC were identified within participating centers of the Strategic Partnering to Evaluate Cancer Signatures program. PD-L1 protein expression by immunohistochemistry was evaluated by using the Dako PD-L1 22C3 pharmDx kit on the Dako Link 48 auto-stainer (Dako, Carpinteria, CA). Tumor mutation burden (TMB) was calculated on the basis of data from targeted genome sequencing. The T-effector and interferon gamma (IFN-γ) gene signature was determined from Affymetrix gene chip data (Affymetrix, Santa Clara, CA) from frozen specimens.Results
The prevalence of PD-L1 expression was 9.8% at a tumor proportion score cutoff of at least 50%. PD-L1 mRNA and programmed cell death 1 ligand 2 mRNA positively correlated with PD-L1 protein expression on tumor cells (TCs) and tumor-infiltrating immune cells. PD-L1 protein expression on tumor-infiltrating immune cells was correlated with the T-effector and IFN-γ gene signature (p < 0.001), but not with TMB. For TCs, all of these biomarkers were independent of each other and neither PD-L1 protein expression, TMB, or T-effector and IFN-γ gene signatures were independently prognostic for patient outcomes.Conclusions
Evaluation of PD-L1 expression, TMB, and T-effector and IFN-γ gene signatures in the cohort with early-stage SqCLC found them to be independent of each other, and none was associated with overall survival. Our results also support the hypothesis that PD-L1 expression is regulated by an intrinsic mechanism on TCs and an adaptive mechanism on immune cells. 相似文献3.
4.
The impact of the financial crisis has been uneven—with differences across industries and occupations. Jobs linked to health care appear better insulated, with nurses specifically showing labor force gains during the recent recession. What is not known is how important public sector employment opportunities are for these national nursing trends. Observing the universe of nurses working for one of the largest (and publicly operated) health care employers, we show that worsening economic conditions lead to stronger job attachment. Relatedly, older nurses also seem more willing to delay retirement and instead transition to part‐time positions during a downturn. 相似文献
5.
Ritu R. Gill Anne S. Tsao Hedy L. Kindler William G Richards Samuel G. Armato Roslyn J. Francis Daniel R. Gomez Suzanne Dahlberg Andreas Rimner Charles B. Simone Marc de Perrot Gideon Blumenthal Alex A. Adjei Raphael Bueno David H. Harpole Mary Hesdorffer Fred R. Hirsch Harvey I. Pass Anna K. Nowak 《Journal of thoracic oncology》2019,14(10):1718-1731
Detailed guidelines pertaining to radiological assessment of malignant pleural mesothelioma are currently lacking due to the rarity of the disease, complex morphology, propensity to invade multiple planes simultaneously, and lack of specific recommendations within the radiology community about assessment, reporting, and follow-up. In March 2017, a multidisciplinary meeting of mesothelioma experts was co-sponsored by the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and the Mesothelioma Applied Research Foundation. One of the outcomes of this conference was the foundation of detailed, multidisciplinary consensus imaging and management guidelines. Here, we present the recommendations for radiologic assessment of malignant pleural mesothelioma in the setting of clinical trial enrollment. We discuss optimization of imaging parameters across modalities, standardized reporting, and response assessment within clinical trials. 相似文献
6.
7.
Christian Mueller Kenneth McDonald Rudolf A. de Boer Alan Maisel John G.F. Cleland Nikola Kozhuharov Andrew J.S. Coats Marco Metra Alexandre Mebazaa Frank Ruschitzka Mitja Lainscak Gerasimos Filippatos Petar M. Seferovic Wouter C. Meijers Antoni Bayes‐Genis Thomas Mueller Mark Richards James L. Januzzi 《European journal of heart failure》2019,21(6):715-731
Natriuretic peptide [NP; B‐type NP (BNP), N‐terminal proBNP (NT‐proBNP), and midregional proANP (MR‐proANP)] concentrations are quantitative plasma biomarkers for the presence and severity of haemodynamic cardiac stress and heart failure (HF). End‐diastolic wall stress, intracardiac filling pressures, and intracardiac volumes seem to be the dominant triggers. This paper details the most important indications for NPs and highlights 11 key principles underlying their clinical use shown below.
- NPs should always be used in conjunction with all other clinical information.
- NPs are reasonable surrogates for intracardiac volumes and filling pressures.
- NPs should be measured in all patients presenting with symptoms suggestive of HF such as dyspnoea and/or fatigue, as their use facilitates the early diagnosis and risk stratification of HF.
- NPs have very high diagnostic accuracy in discriminating HF from other causes of dyspnoea: the higher the NP, the higher the likelihood that dyspnoea is caused by HF.
- Optimal NP cut‐off concentrations for the diagnosis of acute HF (very high filling pressures) in patients presenting to the emergency department with acute dyspnoea are higher compared with those used in the diagnosis of chronic HF in patients with dyspnoea on exertion (mild increase in filling pressures at rest).
- Obese patients have lower NP concentrations, mandating the use of lower cut‐off concentrations (about 50% lower).
- In stable HF patients, but also in patients with other cardiac disorders such as myocardial infarction, valvular heart disease, atrial fibrillation or pulmonary embolism, NP concentrations have high prognostic accuracy for death and HF hospitalization.
- Screening with NPs for the early detection of relevant cardiac disease including left ventricular systolic dysfunction in patients with cardiovascular risk factors may help to identify patients at increased risk, therefore allowing targeted preventive measures to prevent HF.
- BNP, NT‐proBNP and MR‐proANP have comparable diagnostic and prognostic accuracy.
- In patients with shock, NPs cannot be used to identify cause (e.g. cardiogenic vs. septic shock), but remain prognostic.
- NPs cannot identify the underlying cause of HF and, therefore, if elevated, must always be used in conjunction with cardiac imaging.
8.
9.
10.
Huili Zheng Ling Li Foo Huay Cheem Tan Authur Mark Richards Siew Pang Chan Chi-Hang Lee Adrian F.H. Low Derek J. Hausenloy Jack W.C. Tan Anders O. Sahlen Hee Hwa Ho Siang Chew Chai Khim Leng Tong Doreen S.Y. Tan Khung Keong Yeo Terrance S.J. Chua Carolyn S.P. Lam Mark Y. Chan 《The American journal of cardiology》2019,123(12):1935-1940